Application of nervous necrosis virus capsid protein-based antigen-presenting particles for vaccine development

被引:0
作者
Wayha, Sajee [1 ]
Koiwai, Keiichiro [1 ]
Sano, Motohiko [1 ]
Hirono, Ikuo [1 ]
Kondo, Hidehiro [1 ]
机构
[1] Tokyo Univ Marine Sci & Technol, Grad Sch Marine Sci & Technol, Tokyo 1088477, Japan
关键词
Nervous necrosis virus; Capsid protein; Virus-like particles; Vaccine; Japanese flounder; SEA-BASS; IMMUNE-RESPONSE; DNA VACCINE; CELL-DEATH; NODAVIRUS; EXPRESSION; ADJUVANT; FISH;
D O I
10.1016/j.fsi.2024.109803
中图分类号
S9 [水产、渔业];
学科分类号
0908 ;
摘要
Nervous necrosis virus (NNV) capsid protein plays an important role in producing viral particles without any genetic elements. Thus, NNV is a promising candidate for vaccine development and is widely used for constructing vaccines, including DNA, recombinant proteins, and virus-like particles (VLPs). Our study aimed to investigate the potential of NNV capsid protein (NNV) and NNV capsid protein fused to enhanced green fluorescent protein (NNV-EGFP) through VLP formation and whether their application can induce specific antibody responses against certain antigens. We focused on producing DNA and recombinant protein vaccines consisting of the genes for NNV, EGFP, and NNV-EGFP. The approach using NNV-EGFP allowed NNV to act as a carrier or inducer while EGFP was incorporated as part of the capsid protein, thereby enhancing the immune response. In vitro studies demonstrated that all DNA vaccines expressed in HINAE cells resulted in varying protein expression levels, with particularly low levels observed for pNNV and pNNV-EGFP. Consequently, structural proteins derived from HINAE cells could not be observed using transmission electron microscopy (TEM). In contrast, recombinant proteins of NNV and NNV-EGFP were expressed through the Escherichia coli expression system. TEM revealed that rNNV was assembled into VLPs with an approximate size of 30 nm, whereas rNNV-EGFP presented particles ranging from 10 nm to 50 nm in size. For the vaccination test, DNA vaccination marginally induced specific antibody responses in Japanese flounder compared to unvaccinated fish. Meanwhile, NNV and NNVEGFP recombinant vaccines enhanced a greater anti-NNV antibody response than the others, whereas antibody responses against EGFP were also marginal. These results indicate that NNV capsid protein-based antigens, presenting as particles, play an important role in eliciting a specific anti-NNV antibody response and have the potential to improve fish immune responses.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Stability of virus-like particles of red-spotted grouper nervous necrosis virus in the aqueous state, and the vaccine potential of lyophilized particles
    Nguyen Thi Lan
    Kim, Hyoung Jin
    Han, Hyun-Ja
    Lee, Deok-Chan
    Kang, Bo Kyu
    Han, Sang Yoon
    Moon, Hyoungjoon
    Kim, Hong-Jin
    BIOLOGICALS, 2018, 51 : 25 - 31
  • [2] Development of recombinant Yarrowia lipolytica producing virus-like particles of a fish nervous necrosis virus
    Luu, Van-Trinh
    Moon, Hye Yun
    Hwang, Jee Youn
    Kang, Bo-Kyu
    Kang, Hyun Ah
    JOURNAL OF MICROBIOLOGY, 2017, 55 (08) : 655 - 664
  • [3] Protein-Based Nanosystems: Virus-Like-Particles in Modern Vaccine Development
    Reichel, Christoph
    Ruehland, Claus
    Reiser, Christian O. A.
    Hess, Juergen
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2006, 2 (3-4) : 186 - 200
  • [4] Oral immunization with recombinant protein antigen expressed in tobacco against fish nervous necrosis virus
    Cho, Ho Seong
    Seo, Ja Young
    Park, Sang Ik
    Kim, Tae Geum
    Kim, Tae Jung
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2018, 80 (02) : 272 - 279
  • [5] Nervous necrosis virus capsid protein exploits nucleolar phosphoprotein Nucleophosmin (B23) function for viral replication
    Mai, Weijun
    Huang, Fang
    Chen, Huiqing
    Zhou, Yajing
    Chen, Yan
    VIRUS RESEARCH, 2017, 230 : 1 - 6
  • [6] Protein-based nanocages for vaccine development
    Kim, Seong A.
    Lee, Yeram
    Ko, Yeju
    Kim, Seohyun
    Kim, Gi Beom
    Lee, Na Kyeong
    Ahn, Wonkyung
    Kim, Nayeon
    Nam, Gi-Hoon
    Lee, Eun Jung
    Kim, In-San
    JOURNAL OF CONTROLLED RELEASE, 2023, 353 : 767 - 791
  • [7] Protein-based nanoparticles in cancer vaccine development
    Neek, Medea
    Kim, Tae Il
    Wang, Szu-Wen
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2019, 15 (01) : 164 - 174
  • [8] Interaction of papillomavirus virus-like particles with human myeloid antigen-presenting cells
    Lenz, P
    Thompson, CD
    Day, PM
    Bacot, SM
    Lowy, DR
    Schiller, JT
    CLINICAL IMMUNOLOGY, 2003, 106 (03) : 231 - 237
  • [9] Designs of Antigen Structure and Composition for Improved Protein-Based Vaccine Efficacy
    Saylor, Kyle
    Gillam, Frank
    Lohneis, Taylor
    Zhang, Chenming
    FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [10] NMR assignments of protrusion domain of capsid protein from dragon grouper nervous necrosis virus
    Petra Štěrbová
    Danni Wu
    Yuan-Chao Lou
    Chun-Hsiung Wang
    Wei-Hau Chang
    Der-Lii M. Tzou
    Biomolecular NMR Assignments, 2020, 14 : 63 - 66